2[1]Jose A, Bermudez,Moran C,et al.Determination of the steroidogenic capacity in premature ovarian failure. Fertil Steril,1993,60(4):668
3[2]Lawrence C, Martha E, Lee D, et al.Follicle-stimulating hormone beta gene structure in premature ovarian failure. Fertil Steril,1993,60(5):852
4[3]Stampter MJ, Colditz GA,Willett WC, et al. Postmenopausal estrogen therapy and cardiovascular disease:ten year follow-up from the nurse health study.N England J med,1991,325(11):756
5[4]Wren BG.Hormone therapy following breast and uterine cancer Baillieves.Clin Endocrinol Metab,1993,7(1):225
6[5]Michael P, David A, Rossi G,et al. Counter-regulatory response to hypoglycemia in the follicular and lutel phases of the menstrual cycle.Fertil Steril,1993,59(5):988
7[6]Ishizuka B, Kudo Y, Amemiya A,et al. Ovulation induction in a woman with premature ovarian failure resulting from a partial deletion of the X chromosome long arm,46,X,del(X)(q22).Fertil Steril,1997,68(5):931
8Christin-Maitres, Bouehard P [J] .Ann Endoorinol, 1999, 60(2) : 118.
9Kathryn Senior. A genetic explanation for premature ovarian failure?[J] .Lancet, 2001, 357 (3): 367.
10Chernyshov VP,Radysh TV,Gura IV,et al.Immune disorders in women with premature ovarian failure in initial period[J].Am J Reprod Immunol,2000,46(3):220-225.
